- Home
- MAMA vs CMPX Comparison
MAMA vs CMPX Comparison
Compare MAMA & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAMA
- CMPX
- Stock Information
- Founded
- MAMA 2010
- CMPX 2014
- Country
- MAMA United States
- CMPX United States
- Employees
- MAMA N/A
- CMPX 35
- Industry
- MAMA Specialty Foods
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- MAMA Consumer Staples
- CMPX Health Care
- Exchange
- MAMA Nasdaq
- CMPX Nasdaq
- Market Cap
- MAMA 242.9M
- CMPX 291.8M
- IPO Year
- MAMA N/A
- CMPX N/A
- Fundamental
- Price
- MAMA $8.30
- CMPX $2.13
- Analyst Decision
- MAMA Strong Buy
- CMPX Strong Buy
- Analyst Count
- MAMA 3
- CMPX 8
- Target Price
- MAMA $10.67
- CMPX $13.13
- AVG Volume (30 Days)
- MAMA 205.9K
- CMPX 804.2K
- Earning Date
- MAMA 06-03-2025
- CMPX 05-08-2025
- Dividend Yield
- MAMA N/A
- CMPX N/A
- EPS Growth
- MAMA N/A
- CMPX N/A
- EPS
- MAMA 0.09
- CMPX N/A
- Revenue
- MAMA $123,328,000.00
- CMPX $850,000.00
- Revenue This Year
- MAMA $13.59
- CMPX N/A
- Revenue Next Year
- MAMA $12.83
- CMPX N/A
- P/E Ratio
- MAMA $92.33
- CMPX N/A
- Revenue Growth
- MAMA 19.41
- CMPX N/A
- 52 Week Low
- MAMA $5.50
- CMPX $0.77
- 52 Week High
- MAMA $9.98
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- MAMA 77.59
- CMPX 57.65
- Support Level
- MAMA $6.54
- CMPX $2.06
- Resistance Level
- MAMA $8.44
- CMPX $2.23
- Average True Range (ATR)
- MAMA 0.34
- CMPX 0.12
- MACD
- MAMA 0.17
- CMPX 0.01
- Stochastic Oscillator
- MAMA 93.06
- CMPX 69.23
About MAMA Mama's Creations Inc.
Mama's Creations Inc is a marketer and manufacturer of fresh deli-prepared foods, found in grocery, mass, club, and convenience stores nationally. The company's broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high-quality, fresh, clean, and easy-to-prepare foods to address the needs of both consumers and retailers. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.